Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 16647 | 578 | 40.0 | 90% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2015 | 4978 | INTERLEUKIN 10//IL 1RN//INTERLEUKIN 1 BETA GENE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | IL10 GENE | Author keyword | 2 | 67% | 0% | 2 |
| 2 | INTERLEUKIN 10 PROMOTER | Author keyword | 2 | 67% | 0% | 2 |
| 3 | RHEUMATOL INTERNAL MED 3 | Address | 1 | 38% | 1% | 3 |
| 4 | SEKT HUMANPARASITOL | Address | 1 | 15% | 1% | 6 |
| 5 | INTERLEUKIN 10 RECEPTOR | Author keyword | 1 | 18% | 1% | 4 |
| 6 | PEDIAT RHEUMATOL GRP | Address | 1 | 21% | 1% | 3 |
| 7 | ACID | Address | 1 | 50% | 0% | 1 |
| 8 | ACTIVATED LYMPHOCYTE DERIVED DNA | Author keyword | 1 | 50% | 0% | 1 |
| 9 | ANTI DS DNA | Author keyword | 1 | 50% | 0% | 1 |
| 10 | CD169 MACROPHAGE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | IL10 GENE | 2 | 67% | 0% | 2 | Search IL10+GENE | Search IL10+GENE |
| 2 | INTERLEUKIN 10 PROMOTER | 2 | 67% | 0% | 2 | Search INTERLEUKIN+10+PROMOTER | Search INTERLEUKIN+10+PROMOTER |
| 3 | INTERLEUKIN 10 RECEPTOR | 1 | 18% | 1% | 4 | Search INTERLEUKIN+10+RECEPTOR | Search INTERLEUKIN+10+RECEPTOR |
| 4 | ACTIVATED LYMPHOCYTE DERIVED DNA | 1 | 50% | 0% | 1 | Search ACTIVATED+LYMPHOCYTE+DERIVED+DNA | Search ACTIVATED+LYMPHOCYTE+DERIVED+DNA |
| 5 | ANTI DS DNA | 1 | 50% | 0% | 1 | Search ANTI+DS+DNA | Search ANTI+DS+DNA |
| 6 | CD169 MACROPHAGE | 1 | 50% | 0% | 1 | Search CD169+MACROPHAGE | Search CD169+MACROPHAGE |
| 7 | CD62L EXPRESSION | 1 | 50% | 0% | 1 | Search CD62L+EXPRESSION | Search CD62L+EXPRESSION |
| 8 | CYTOPLASMIC CYTOKINE | 1 | 50% | 0% | 1 | Search CYTOPLASMIC+CYTOKINE | Search CYTOPLASMIC+CYTOKINE |
| 9 | IGM ANTICARDIOLIPIN ANTIBODY | 1 | 50% | 0% | 1 | Search IGM+ANTICARDIOLIPIN+ANTIBODY | Search IGM+ANTICARDIOLIPIN+ANTIBODY |
| 10 | IL10 GENE POLYMORPHISM | 1 | 50% | 0% | 1 | Search IL10+GENE+POLYMORPHISM | Search IL10+GENE+POLYMORPHISM |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | B LYMPHOCYTE HYPERACTIVITY | 34 | 60% | 6% | 37 |
| 2 | HUMAN IL 10 LOCUS | 19 | 61% | 3% | 20 |
| 3 | IMPAIRED PRODUCTION | 5 | 39% | 2% | 11 |
| 4 | POLYMORPHIC DINUCLEOTIDE REPEAT | 5 | 40% | 2% | 10 |
| 5 | INTERLEUKIN 10 GENE PROMOTER | 5 | 25% | 3% | 16 |
| 6 | IL 10 LOCUS | 3 | 27% | 2% | 11 |
| 7 | IL10 HAPLOTYPES | 3 | 60% | 1% | 3 |
| 8 | CELL DERIVED IL 10 | 2 | 67% | 0% | 2 |
| 9 | G ALLELE | 2 | 67% | 0% | 2 |
| 10 | PROMOTER POLYMORPHISMS INFLUENCE | 2 | 67% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Association of the -1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus: A meta-analysis | 2013 | 7 | 37 | 65% |
| Etanercept in refractory lupus arthritis: An observational study | 2015 | 1 | 38 | 24% |
| Therapeutic blockade of TNF in patients with SLE-Promising or crazy? | 2012 | 23 | 67 | 28% |
| The role of tumor necrosis factor-alpha in systemic lupus erythematosus | 2008 | 66 | 62 | 26% |
| Cytokines and systemic lupus erythematosus | 2000 | 136 | 69 | 49% |
| Mosaics of gene variations in the interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used | 2004 | 60 | 33 | 55% |
| Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus | 2013 | 6 | 121 | 45% |
| IL-10 and TNF alpha Genotypes in SLE | 2010 | 24 | 109 | 37% |
| Interleukin-10-592C/A,-819C/T and-1082A/G Polymorphisms with Risk of Type 2 Diabetes Mellitus: A HuGE Review and Meta-analysis | 2013 | 4 | 17 | 53% |
| Cytokine disturbances in systemic lupus erythematosus | 2011 | 24 | 112 | 22% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RHEUMATOL INTERNAL MED 3 | 1 | 38% | 0.5% | 3 |
| 2 | SEKT HUMANPARASITOL | 1 | 15% | 1.0% | 6 |
| 3 | PEDIAT RHEUMATOL GRP | 1 | 21% | 0.5% | 3 |
| 4 | ACID | 1 | 50% | 0.2% | 1 |
| 5 | CLIN MEDSECT NEUROL | 1 | 50% | 0.2% | 1 |
| 6 | HANS WILDORF | 1 | 50% | 0.2% | 1 |
| 7 | HIV VACCINE TRIALS | 1 | 50% | 0.2% | 1 |
| 8 | IMMUNOHEMATOL BLOOD TRANSFUS UNIT | 1 | 50% | 0.2% | 1 |
| 9 | IMMUNOL COMPLEMENT | 1 | 50% | 0.2% | 1 |
| 10 | INTERNAL MED 2RHEUMATOL | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000229203 | IL 10R1//VIRAL IL 10//INTERLEUKIN 10 RECEPTOR |
| 2 | 0.0000187823 | IL 1RN//INTERLEUKIN 1 BETA GENE//INTERLEUKIN 1B |
| 3 | 0.0000171405 | TNF ALPHA GENE POLYMORPHISM//MOL LIFESCI//VA NEGOVSKY GEN REANIMATOL |
| 4 | 0.0000146707 | INTERDISCIPLINARY GERIATR ASSOC//INTERLEUKIN 6 POLYMORPHISM//UNIT BIOL GENET CANC HAEMATOL AUTOIMMUNE |
| 5 | 0.0000144674 | DERRIFORD COMBINED S//CYTOKINE GENE POLYMORPHISM//CLINICIZZATA CHIRURG 2 |
| 6 | 0.0000137363 | NEW ZEALAND MICE//RHEUMATOL CLIN MED//MRL LPR MICE |
| 7 | 0.0000127787 | UNC93B1//MARY KIRKLAND LUPUS//TLR7 |
| 8 | 0.0000086826 | BAFF//APRIL//BLYS |
| 9 | 0.0000081211 | ANTI TNF ALPHA THERAPIES//GENHOTEL RECH EUROPEEN POLYARTHRITE RHUMATOID//PATHOL RHEUMATOL |
| 10 | 0.0000078699 | DRUG INDUCED LUPUS//DRUG INDUCED LUPUS ERYTHEMATOSUS//TNF ALPHA ANTAGONISTS |